14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.22 $1.62 Friday, 3rd May 2024 AKBA stock ended at $1.37. This is 5.38% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 7.58% from a day low at $1.32 to a day high of $1.42.
90 days $1.22 $2.47
52 weeks $0.780 $2.47

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
Jun 17, 2020 $12.30 $12.50 $12.04 $12.19 795 344
Jun 16, 2020 $12.35 $12.52 $12.03 $12.30 1 058 310
Jun 15, 2020 $10.95 $12.13 $10.95 $12.13 1 389 443
Jun 12, 2020 $10.95 $11.20 $10.56 $11.19 1 402 028
Jun 11, 2020 $11.25 $11.38 $10.52 $10.53 1 162 410
Jun 10, 2020 $12.09 $12.09 $11.37 $11.43 842 831
Jun 09, 2020 $11.73 $12.06 $11.43 $11.84 1 043 685
Jun 08, 2020 $12.10 $12.18 $11.79 $11.82 841 004
Jun 05, 2020 $12.36 $12.64 $11.87 $11.96 1 200 696
Jun 04, 2020 $11.85 $12.22 $11.74 $12.18 1 875 153
Jun 03, 2020 $11.34 $11.97 $11.25 $11.89 1 813 255
Jun 02, 2020 $11.09 $11.35 $10.64 $11.31 1 366 141
Jun 01, 2020 $11.57 $11.90 $11.17 $11.17 1 151 286
May 29, 2020 $11.62 $11.69 $10.97 $11.64 2 230 452
May 28, 2020 $12.36 $12.57 $11.42 $11.51 1 179 666
May 27, 2020 $12.16 $12.40 $11.71 $12.30 1 308 644
May 26, 2020 $12.48 $12.73 $12.13 $12.15 990 546
May 22, 2020 $12.41 $12.42 $12.00 $12.16 689 556
May 21, 2020 $12.54 $12.62 $12.12 $12.43 806 800
May 20, 2020 $12.13 $12.76 $11.95 $12.64 1 267 768
May 19, 2020 $12.06 $12.35 $11.87 $11.89 1 082 851
May 18, 2020 $12.71 $13.02 $11.89 $12.10 1 696 122
May 15, 2020 $12.20 $12.84 $12.12 $12.42 1 562 158
May 14, 2020 $11.56 $12.16 $11.35 $12.12 1 906 301
May 13, 2020 $11.50 $12.05 $11.34 $11.81 2 487 246
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT